Clinic
Convenientmd LLC
Convenientmd LLC was paid $645K by Medicaid between Jan 2018 and Aug 2023, across 21 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 26% of everything it billed.
33Billing provider infoCONVENIENTMD LLC
WESTBROOK, ME 04092
WESTBROOK, ME 04092
33aNPI1710402359assigned 08/04/2017
33bProvider typeUrgent Care Clinic/Center
28Total paid$645K
24GClaims16,969
24DCodes billed21
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Urgent Care Clinic/Center providers in Maine
Rank by total paid#5 of 28
Median peer was paid$297K
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DICKENS, GARETH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 751 | $36K | |
| 2019 | 1,164 | $40K | |
| 2020 | 2,280 | $85K | |
| 2021 | 6,736 | $234K | |
| 2022 | 4,226 | $175K | |
| 2023 | 1,812 | $76K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 26% | 2,595 | 2,458 | $168K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 3,064 | 2,579 | $155K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15% | 2,134 | 1,966 | $95K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 2,836 | 2,662 | $93K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.5% | 658 | 561 | $49K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6.5% | 2,595 | 2,458 | $42K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.5% | 562 | 551 | $16K |
| 87428 | 1.5% | 389 | 368 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.0% | 541 | 506 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 421 | 355 | $4K |
| 90686 | <1% | 124 | 120 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 138 | 133 | $2K |
9 more codes
| 99000 | <1% | 296 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 66 | $631.34 |
| 90756 | <1% | 22 | $512.00 | |
| 90674 | <1% | 13 | $288.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15 | $200.72 |
| A9150 | Non-prescription drugs | 0% | 84 | $0.00 |
| H0033 | Oral medication administration, direct observation | 0% | 230 | $0.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 172 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDICKENS, GARETH (CO-CEO)
| Provider | Location | Paid |
|---|---|---|
| Convenientmd LLC | Concord, NH | $1.68M |
| Convenientmd LLC | Bellingham, MA | $1.25M |
| Convenientmd LLC | Stratham, NH | $1.19M |
| Convenientmd LLC | Keene, NH | $1.14M |
| Convenientmd LLC | Newburyport, MA | $1.05M |
| Convenientmd LLC | Merrimack, NH | $993K |
| Convenientmd LLC | Quincy, MA | $987K |
| Convenientmd LLC | Dover, NH | $923K |
| Convenientmd LLC | Belmont, NH | $922K |
| Convenientmd LLC | Weymouth, MA | $900K |
| Convenientmd LLC | Falmouth, MA | $832K |
| Convenientmd LLC | Nashua, NH | $802K |
| Convenientmd LLC | Portsmouth, NH | $796K |
| Convenientmd LLC | Plainville, MA | $683K |
| Convenientmd LLC | Bangor, ME | $659K |
| Convenientmd LLC | Windham, NH | $645K |
| Convenientmd LLC | Pembroke, MA | $578K |
| Convenientmd LLC | Littleton, NH | $434K |
| Convenientmd LLC | Saco, ME | $432K |
| Convenientmd LLC | Bedford, NH | $427K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.